CIABATTONI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 6.232
AS - Asia 4.265
EU - Europa 4.108
SA - Sud America 392
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 15.061
Nazione #
US - Stati Uniti d'America 6.131
SG - Singapore 1.656
CN - Cina 1.209
UA - Ucraina 813
TR - Turchia 645
IE - Irlanda 605
GB - Regno Unito 568
SE - Svezia 506
RU - Federazione Russa 498
FR - Francia 343
BR - Brasile 327
DE - Germania 316
VN - Vietnam 285
FI - Finlandia 200
IN - India 191
IT - Italia 164
BD - Bangladesh 76
CA - Canada 47
MX - Messico 35
HK - Hong Kong 33
AR - Argentina 26
PL - Polonia 22
KR - Corea 21
ZA - Sudafrica 21
IQ - Iraq 19
CZ - Repubblica Ceca 15
ID - Indonesia 15
PK - Pakistan 15
JP - Giappone 14
ES - Italia 13
SA - Arabia Saudita 11
EC - Ecuador 10
NL - Olanda 10
EU - Europa 9
IL - Israele 9
AT - Austria 8
PH - Filippine 8
UZ - Uzbekistan 8
IR - Iran 7
VE - Venezuela 7
CO - Colombia 6
JO - Giordania 6
LT - Lituania 6
MA - Marocco 6
DZ - Algeria 5
EG - Egitto 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
JM - Giamaica 4
LB - Libano 4
OM - Oman 4
PY - Paraguay 4
QA - Qatar 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
AU - Australia 3
BE - Belgio 3
BO - Bolivia 3
HN - Honduras 3
KG - Kirghizistan 3
NI - Nicaragua 3
RO - Romania 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
BB - Barbados 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CL - Cile 2
CR - Costa Rica 2
GD - Grenada 2
KZ - Kazakistan 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 15.061
Città #
Singapore 1.242
Jacksonville 857
San Jose 741
Chandler 740
Dublin 602
Southend 454
Ashburn 348
Beijing 315
Princeton 314
Izmir 311
Dallas 241
Nanjing 202
Wilmington 184
Santa Clara 182
Los Angeles 156
Cambridge 143
Dearborn 132
Tongling 107
Council Bluffs 97
Ho Chi Minh City 94
Munich 83
Buffalo 82
New York 80
The Dalles 76
Nanchang 74
Woodbridge 68
Moscow 66
Hanoi 61
Ann Arbor 60
Boardman 58
Shenyang 45
Altamura 40
São Paulo 35
Hebei 34
Kunming 34
Tianjin 34
Grevenbroich 33
Washington 33
Helsinki 30
Changsha 28
Jiaxing 28
Turku 28
Brooklyn 27
Hong Kong 27
Houston 27
Norwalk 24
Denver 22
Chennai 20
Seoul 20
Montreal 19
Orem 19
Haiphong 18
Hangzhou 18
Redondo Beach 17
Warsaw 17
Atlanta 16
Da Nang 16
Hefei 16
Augusta 15
Chieti 15
Orange 15
Falls Church 14
Poplar 14
Tokyo 14
Frankfurt am Main 13
Jinan 13
Johannesburg 13
San Mateo 13
Boston 12
Chicago 12
Seattle 12
Toronto 11
Baghdad 10
Brno 10
Mexico City 10
Phoenix 10
Rome 9
Stockholm 9
Belo Horizonte 8
Changchun 8
Lanzhou 8
Rio de Janeiro 8
San Francisco 8
Zhengzhou 8
Auburn Hills 7
Brasília 7
Leawood 7
Mumbai 7
Amsterdam 6
Ankara 6
Biên Hòa 6
Guayaquil 6
London 6
Manchester 6
Milan 6
Querétaro 6
Roubaix 6
Shanghai 6
Tashkent 6
Amman 5
Totale 9.286
Nome #
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 189
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 173
Amylin inhibits hypothalamic dopamine release. 160
Determinants of platelet activation in hypertensives with microalbuminuria. 154
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 154
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 151
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 151
Aging increases amyloid beta-peptide-induced 8-iso-prostaglandin F2alpha release from rat brain. 150
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 150
Chromatin derived acid peptides inhibit dopamine and norepinephrine release in the hypothalamus. 149
Effect of CART peptide-(55-102), leptin and orexin-B on hypothalamicserotonin release. 146
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 144
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 143
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 141
Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during neutrophil granulocytic differentiation and contributes to maturation. 141
Anterior pituitary cell production of 8-iso-prostaglandin F2alpha. 140
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 138
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 137
8-Isoprostane in exhaled breath condensate (EBC)and excercise-induced bronchoconstriction in asthmatic children and adolescents 136
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 135
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 135
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 134
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 134
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. 133
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X 132
Insulin resistance as a determinant of platelet activation in obese women. 132
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 130
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 128
Increased thromboxane biosynthesis in essential thrombocythemia 126
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 126
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 126
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 125
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 124
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 124
Determinants of platelet activation in hypertensives with microalbuminuria. 123
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 123
Problemi di metodologia per la individuazione del rischio tossicologico. Consiglio Nazionale delle Ricerche 122
Soluble RAGE in type 2 diabetes: association with oxidative stress. 122
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 121
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 121
Association between PAI-1 and Oxidative Stress in Android Obesity 121
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 121
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 120
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 119
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 119
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. 117
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 117
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 116
Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. 115
Drugs, prostaglandins, and renal function. 115
Determinants of platelet activation in Alzheimer's disease 115
Role of Platelet Activation in Dementia 114
Effects of anthracyclines on hypothalamic dopamine release. 114
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 114
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 113
Anaphylaxis increases 8-iso-PGF2alpha release from guinea-pig lung in vitro 113
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 113
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 112
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 112
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 111
Measurement of 8-isoprostane in exhaled breath condensate. 111
Tachykinin-eicosanoid crosstalk in airway inflammation 110
Effects of cocaine- and amphetamine-regulated transcript peptide, leptin and orexins on hypothalamic serotonin release. 110
Insulin resistance as a determinant of platelet activation in obese women 110
Increased exhaled 8-isoprostane in childhood asthma. 107
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 107
Platelet activation in obese women: role of inflammation and oxidant stress. 106
Determinants of Platelet Activation in Heart Failure. 106
Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers 105
Effect of gherlin and amylin on hypothalamic dopamine, norepinephrine and serotonin release. 105
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 105
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 105
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 105
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 104
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 103
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype 101
Induced sputum, exhaled breath condensate and nasal lavage fluid in electroplating workers exposed to chromium 100
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 100
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 100
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 100
Platelet Activation Markers in Patients with Peripheral Arterial Disease. A Prospective Comparison of Different Platelet Function Tests 100
Validation of leukotriene B4 measurements in exhaled breath condensate. 99
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erytrhopoiesis. 99
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 97
Determinants of Platelet Activation in Heart Failure. 97
Identification of 8-iso-prostaglandin (PG) F2alfa in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 96
Identification of 8-iso-prostaglandin F2alpha in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 96
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 96
Soluble CD40L as an indicator of platelet Activation in Heart Failure 96
Effects of montelukast treatment and withhdrawal on fractional exhaled nitric oxide and lung function in children with asthma 95
Effects of atorvastatin and rosuvastatin on throboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 95
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 94
Increased macrothrombocytopenia with distinctive platelet ultrastructural and functional features 94
Oxidative stress and platelet activation in children and adolescents with type 1 diabetes: role of interleukin-6 94
Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. 93
Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzima-A inhibitor sinvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. 93
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 93
Inherited Macrothrombocytopenia with Distinctive Platelet Ultrastructural and Functional Features 92
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 92
Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate. 91
Totale 11.836
Categoria #
all - tutte 58.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 0 0 33
2021/2022598 17 7 4 118 71 9 11 43 45 11 78 184
2022/20231.930 159 197 126 222 189 447 115 134 233 19 39 50
2023/2024801 62 33 60 22 48 256 216 25 2 7 9 61
2024/20252.395 149 524 484 28 19 55 20 91 174 64 277 510
2025/20264.388 429 255 407 464 423 299 801 213 470 364 192 71
Totale 15.309